Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cdt Equity Inc (CDT)

Cdt Equity Inc (CDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cdt Equity Inc 4581 Tamiami Trail North Suite 200 Naples FL 34103 USA

www.conduitpharma.com Employees: 6 P: 646-491-9132

Sector:

Medical

Description:

CDT Equity Inc. is a data-driven biotech development company focused on identifying, enhancing and advancing therapeutic assets through scientific innovation and strategic partnerships. CDT Equity Inc., formerly known as Conduit Pharmaceuticals Inc., is based in NAPLES, Fla.

Key Statistics

Overview:

Market Capitalization, $K 2,591
Enterprise Value, $K 2,041
Shares Outstanding, K 1,629
Annual Sales, $ 0 K
Annual Net Income, $ -17,800 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,120 K
EBIT, $ -19,500 K
EBITDA, $ -16,450 K
60-Month Beta 1.78
% of Insider Shareholders 7.72%
% of Institutional Shareholders 3.29%
Float, K 1,504
% Float 92.28%
Short Interest 89
Short Float 5.44%
Short Volume Ratio 0.80

Growth:

1-Year Return -99.78%
3-Year Return -100.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -13.16 on 11/13/25
Next Earnings Date 03/27/26
Earnings Per Share ttm -2,653.54
EPS Growth vs. Prev Qtr 69.87%
EPS Growth vs. Prev Year 98.43%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 10/13/25

CDT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2,022.28%
Return-on-Assets % -291.03%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.50
Book Value/Share 3.17
Interest Coverage -10.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar